Acupuncture Versus Sham for Radiotherapy-Induced Emesis
Launched by UNIVERSITY HOSPITAL, LINKOEPING · Feb 21, 2008
Trial Information
Current as of June 02, 2025
Completed
Keywords
ClinConnect Summary
Treatment with acupuncture is, despite sometimes unclear evidence, increasing in cancer care. Acupuncture is used for indications such as pain and nausea, but for radiotherapy (RT) induced nausea it is still an unexplored treatment. For evaluation of the method, the use of sham acupuncture as a control treatment provides a tool resembling placebo for drugs. The aim of the studt is therefore to investigate whether acupuncture reduces nausea caused by radiotherapy in a patient group with a \>50% risk of experiencing the symptoms (abdominal or pelvic region). Patients are randomised to invasiv...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients of at least 18 years of age
- • with gynaecologic-, anal-, rectal-, colon-, ventricle-, pancreatic- or testicular tumours
- • willing to give their informed consent
- • able to take part in the entire treatment and data collection procedure
- • had planned radiation over an abdominal and/or pelvic field (with or without concomitant chemotherapy) with the volume of at least 800 cm3 and a dose of at least 25 Gy.
- Exclusion Criteria:
- • use of antiemetic treatment or persistent nausea within 24 hours prior to the start of radiotherapy
- • ever received acupuncture against nausea, or during the last year received acupuncture for any indication.
About University Hospital, Linkoeping
The University Hospital in Linköping is a leading academic medical center renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pivotal institution within the region, it integrates cutting-edge medical practices with academic excellence, facilitating a collaborative environment for healthcare professionals and researchers. The hospital actively participates in a wide range of clinical trials across various medical disciplines, aiming to enhance patient outcomes and contribute to the global body of medical knowledge. With a focus on ethical standards and patient safety, the University Hospital in Linköping is dedicated to pioneering solutions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Linköping, , Sweden
Patients applied
Trial Officials
Sussanne Börjeson, PhD
Principal Investigator
Linkoeping University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials